RELX PLC (REL) Stock Today – Share Buybacks, New Institutional Buying and 2026 Outlook on 26 November 2025

RELX PLC (REL) Stock Today – Share Buybacks, New Institutional Buying and 2026 Outlook on 26 November 2025

London – 26 November 2025 – RELX PLC (LON: REL, NYSE: RELX), the information‑analytics group behind brands such as LexisNexis and Elsevier, is back in focus today as the company continues a heavy share‑buyback programme and attracts fresh institutional interest, even while its share price trades close to 12‑month lows.

Below is a rundown of the key RELX news and market drivers relevant as of 26 November 2025.


RELX share price today: trading near the bottom of its 52‑week range

On the London Stock Exchange, RELX closed yesterday (25 November) at 3,059p, giving the group a market capitalisation of roughly £55.6bn. [1]

  • LSE data for today show an opening price of 3,063p, slightly above yesterday’s close, on strong early trading volumes of around 5.7 million shares. [2]
  • Technical analysts at StockInvest calculate a 52‑week high of 4,205p and a 52‑week low of 3,011p, underlining how far the stock has fallen from its peak. [3]

For US investors, the New York‑listed ADR last closed at $40.37, also close to its 12‑month low of $39.31 and well below the high of $56.33. [4]

At an index level, the FTSE 100 is edging higher today, but RELX has been cited among the blue‑chip names trading modestly lower (about ‑0.6% intraday) as investors position themselves ahead of the UK budget announcement. [5]

In short: fundamentals remain strong, but the shares are still digesting a sharp correction from 2024–early‑2025 highs.


Fresh institutional buying reported today

One of the clearest pieces of new RELX news dated 26 November 2025 comes from US regulatory filings:

  • AlphaCore Capital LLC has disclosed a new stake of 2,529 RELX ADRs (NYSE: RELX), worth around $137,000, in its latest Form 13F filing with the SEC. [6]
  • The same report highlights a broader institutional bid for the stock:
    • ABC Arbitrage SA increased its RELX holdings by nearly 189% in Q2, to about 560,958 shares.
    • Ameriprise Financial, Connor Clark & Lunn and Northern Trust all added to their positions earlier in the year. [7]

While AlphaCore’s purchase is small in absolute terms, it reinforces a pattern: RELX remains a core holding for many global funds, even after the recent pull‑back.

That picture is echoed on the fund side:

  • The Finsbury Growth & Income Trust, a prominent UK equity investment trust, lists RELX as its second‑largest position at about 12.6% of assets in a factsheet dated 26 November 2025. [8]
  • RELX is also a top‑ten constituent (around 3% weight) in the SPDR MSCI Europe Industrials UCITS ETF, making it a structural holding in European industrials portfolios. [9]

Taken together, today’s filings and factsheets underline that long‑only institutional investors still see RELX as a high‑quality compounder, even if near‑term sentiment is fragile.


Ongoing share buyback: 60,041 more shares repurchased

The other big theme in RELX news flow around 26 November 2025 is the company’s aggressive share‑buyback programme.

Latest transaction: 25 November 2025

A regulatory filing shows that on 25 November 2025, RELX:

  • Bought back 60,041 ordinary shares on the London Stock Exchange.
  • The purchases were executed by JP Morgan Securities plc.
  • The volume‑weighted average price was about 3,043p, with trades ranging between roughly 3,031p and 3,061p. [10]

These shares will be held as treasury stock, reducing free float and supporting earnings per share over time.

Year‑to‑date scale of the buyback

An earlier RNS on 20 November 2025 stated that:

  • RELX had already repurchased approximately 39.1 million shares since 2 January 2025.
  • Following that day’s 61,554‑share buyback, RELX held around 58.8 million shares in treasury, with about 1.82 billion shares in issue. [11]

Additional regulatory disclosures in the Dutch AFM “inside information” register confirm near‑daily “transaction in own shares” notices for RELX through October and November, reinforcing the consistent pace of repurchases. [12]

The group’s November 2025 investor overview also shows that RELX expects to deploy roughly £1.5bn on buybacks in 2025, alongside a dividend payout of around 50% of adjusted earnings, within a comfortable net‑debt‑to‑EBITDA range of about 1.8–2.5x. [13]

Why it matters: at current depressed share prices, every pound spent on buybacks cancels more shares, amplifying EPS growth and providing a floor for the valuation if fundamentals hold up.


Fundamentals: solid growth in 2025 so far

Behind the volatile share price, RELX continues to report resilient trading in 2025.

H1 2025 results: double‑digit profit growth

In its first‑half results and later investor overview, RELX reported for H1 2025: [14]

  • Underlying revenue growth: about +7%
  • Underlying adjusted operating profit: up around +9%
  • Adjusted EPS at constant currency: up +8%
  • Interim dividend: raised 7% year‑on‑year

Margins also continued to expand, with adjusted operating margin rising towards the mid‑30s and EBITDA margin over 40%, continuing a decade‑long trend of gradual improvement. [15]

October 2025 trading update: guidance intact

On 23 October 2025, RELX issued a year‑to‑date trading update indicating: [16]

  • Underlying revenue growth of about +5% for the year so far.
  • “Good growth” across all major segments – Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions.
  • Momentum driven by a shift in the business mix towards higher‑growth, higher‑value analytics and decision tools, with renewal rates and new sales ahead of the prior year.

Management reiterated expectations for another year of strong underlying growth in revenue, adjusted operating profit and adjusted EPS for 2025, in line with the recent run of high‑single‑digit growth.

Business mix: data, analytics and AI

RELX’s own overview slides break the business down into four main segments: [17]

  • Risk – information‑based analytics and decision tools used by banks, insurers and corporates for fraud detection, credit scoring and compliance.
  • STM (Elsevier) – scientific and medical information, data and analytics supporting research and healthcare decisions.
  • Legal (LexisNexis) – legal research, workflow and analytics, increasingly powered by AI and big data.
  • Exhibitions – Reed Exhibitions, focusing on trade shows and events across many industries.

RELX is heavily invested in AI‑driven products – from predictive risk models to legal analytics – and its brands continue to show up in policy debates. For example, LexisNexis data services are mentioned in coverage of draft EU online‑safety and anti‑child‑abuse legislation, underscoring the company’s role in compliance and digital‑safety infrastructure. [18]


How the market is reading RELX today

Technical picture: negative bias in the short term

Despite solid fundamentals, short‑term technical models are cautious:

  • StockInvest assigns both REL.L (London) and RELX (NYSE) a “Sell candidate” rating, noting that each share class sits in a broad falling trend with several negative momentum signals. [19]
  • For London, they highlight support around 3,057p and resistance near 3,136p, with average daily volatility close to 2%. [20]
  • In New York, the site flags the ADR as oversold on RSI‑14 (~21), with support around $40.35 and resistance above $45. [21]

In parallel, macro news today shows the FTSE 100 inching up while RELX trades slightly softer, suggesting that some investors are still trimming positions into rallies after a long multi‑year bull run in the stock. [22]

Analyst sentiment: still broadly positive

On the fundamental side, sentiment remains more constructive:

  • An auto‑generated note on TipRanks today, summarising the latest buyback announcement, cites the most recent broker rating on RELX as “Buy” with a price target around £33.48, comfortably above the current ~£30 level. The platform’s AI analyst “Spark” categorises the stock as an “Outperform”, albeit with warnings about near‑term technical weakness and rich valuation multiples. [23]
  • A Seeking Alpha analysis from October argued that the recent “price correction represents a buying opportunity”, highlighting RELX’s AI‑driven growth, high margins and strong competitive moat as reasons the stock still looks attractive versus global data‑analytics peers. [24]

In other words, fundamental analysts mostly like the business, but quantitative and technical models are cautious on the chart.


What today’s developments mean for investors

Putting today’s 26 November 2025 news into context:

  1. Buybacks remain a powerful tailwind
    • RELX is on track to retire tens of millions of shares in 2025 alone, with over £1.5bn earmarked for repurchases. [25]
    • At today’s depressed prices, this is likely to be EPS‑accretive and supports the long‑term investment case, provided growth holds up.
  2. Institutional appetite is still there
    • Fresh buying by AlphaCore Capital and large positions in vehicles such as Finsbury Growth & Income Trust and SPDR’s MSCI Europe Industrials ETF show that RELX remains a core conviction holding across multiple mandates. [26]
  3. Valuation has de‑rated significantly
    • With shares sitting close to their 52‑week lows in both London and New York, a lot of pessimism has already been priced in after a multi‑year run. [27]
  4. Short‑term risk is still high
    • Technical indicators and trend‑following models point to a weak near‑term outlook, and intraday moves remain sharp, as today’s FTSE trading shows. [28]
  5. Long‑term story hinges on AI, data and regulation
    • RELX’s success depends on staying ahead in AI‑powered analytics, deepening integration into client workflows and navigating an increasingly complex regulatory environment in areas like data privacy, online safety and financial crime. [29]

Key things to watch from here

Looking beyond today’s headlines, here are the main catalysts and risk factors for RELX investors:

  • Next results statement – Data providers currently flag mid‑February 2026 as the likely window for full‑year 2025 results, though RELX has not yet formally confirmed the date on its own calendar. [30]
  • Pace of buybacks – Continued “transaction in own shares” RNS notices will show whether the company accelerates repurchases at current levels. [31]
  • Macro sensitivity – The Exhibitions division is more cyclical and could wobble if global trade shows or business travel slow, while the stronger US dollar can both help and hurt reported numbers depending on hedging. [32]
  • Regulatory changes – New rules on data, AI and online content in the EU and US can reshape demand for compliance and risk‑management tools – a potential growth driver but also a source of uncertainty. [33]

Bottom line

On 26 November 2025, RELX PLC sits at an interesting crossroads:

  • Operationally, the group is still delivering mid‑ to high‑single‑digit revenue and double‑digit profit growth, backed by sticky subscription revenues and strong positions in risk, legal and scientific analytics. [34]
  • Financially, it continues to return substantial cash via growing dividends and sizeable buybacks. [35]
  • In the market, however, the shares are trading close to their 12‑month lows and are rated cautiously by technical models, even as institutional money quietly adds on weakness. [36]

For investors, today’s mix of fresh buyback activity, new institutional interest and cheapened valuation on the one hand, and negative technical momentum on the other, makes RELX a classic “quality at a crossroads” story to watch as the company heads into its 2026 reporting season.


This article is for information only and does not constitute investment advice. Always do your own research or consult a qualified financial adviser before making investment decisions.

References

1. stockinvest.us, 2. www.londonstockexchange.com, 3. stockinvest.us, 4. stockinvest.us, 5. www.tradingview.com, 6. www.defenseworld.net, 7. www.defenseworld.net, 8. lt.morningstar.com, 9. www.ssga.com, 10. www.tradingview.com, 11. markets.ft.com, 12. www.afm.nl, 13. www.relx.com, 14. finance.yahoo.com, 15. www.relx.com, 16. www.relx.com, 17. www.relx.com, 18. www.mlex.com, 19. stockinvest.us, 20. stockinvest.us, 21. stockinvest.us, 22. www.tradingview.com, 23. www.tipranks.com, 24. seekingalpha.com, 25. www.relx.com, 26. www.defenseworld.net, 27. stockinvest.us, 28. www.tradingview.com, 29. www.relx.com, 30. stockinvest.us, 31. www.investegate.co.uk, 32. www.relx.com, 33. www.mlex.com, 34. www.relx.com, 35. www.relx.com, 36. www.defenseworld.net

GSK News Today (26 November 2025): Medicare Slashes Prices on Trelegy, Berenberg Lifts Target, and Buybacks Signal Confidence
Previous Story

GSK News Today (26 November 2025): Medicare Slashes Prices on Trelegy, Berenberg Lifts Target, and Buybacks Signal Confidence

British American Tobacco (BATS) Share Price Today: Buyback Update, JP Morgan Target Hike and Dividend Focus – 26 November 2025
Next Story

British American Tobacco (BATS) Share Price Today: Buyback Update, JP Morgan Target Hike and Dividend Focus – 26 November 2025

Go toTop